Jack W. Singer
2015
In 2015, Jack W. Singer earned a total compensation of $3.2M as Executive Vice President, Chief Scientific Officer, Interim Chief Medical Officer and Global Head of Translational Medicine at CTI BioPharma, a 50% increase compared to previous year.
Compensation breakdown
| Bonus | $111,000 |
|---|---|
| Option Awards | $1,563,510 |
| Salary | $370,000 |
| Stock Awards | $1,126,322 |
| Other | $39,102 |
| Total | $3,209,934 |
Singer received $1.6M in option awards, accounting for 49% of the total pay in 2015.
Singer also received $111K in bonus, $370K in salary, $1.1M in stock awards and $39.1K in other compensation.
Rankings
In 2015, Jack W. Singer's compensation ranked 2,917th out of 13,638 executives tracked by ExecPay. In other words, Singer earned more than 78.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,917 out of 13,638 | 79th |
Division Manufacturing | 1,030 out of 5,187 | 80th |
Major group Chemicals And Allied Products | 381 out of 1,857 | 80th |
Industry group Drugs | 298 out of 1,531 | 81st |
Industry Pharmaceutical Preparations | 237 out of 1,179 | 80th |
Source: SEC filing on March 28, 2017.
Singer's colleagues
We found four more compensation records of executives who worked with Jack W. Singer at CTI BioPharma in 2015.